Effect of mitomycin C on the secretion of granulocyte macrophages colonies stimulating factor and interleukin-5 in eosinophilic nasal polyps stromal culture
- PMID: 16446960
- PMCID: PMC9441983
- DOI: 10.1016/s1808-8694(15)31199-x
Effect of mitomycin C on the secretion of granulocyte macrophages colonies stimulating factor and interleukin-5 in eosinophilic nasal polyps stromal culture
Abstract
The research involving tissue factors, such as granulocyte macrophage colonies stimulating factor (GM-CSF) and interleukin 5 (IL-5), leads to the mechanisms involved in the maintenance of eosinophilia, which is essential for the pathogenesis on eosinophilic nasal polyps. Mitomycin C has been successfully used in otolaryngology.
Aim: The objective of this study was to evaluate the effect of mitomycin C in secretion of GM-CSF and IL-5 on eosinophilic nasal polyps.
Study design: Case-control.
Material and method: This is a comparative and auto-matched experimental study, performed with fragments of polyps which had been obtained from biopsy of patients with eosinophilic nasosinusal polyposis. The fragments of the experimental group were treated with mitomycin C (400 microg/ml) for 5 minutes and then washed in RPMI substrate. At time zero, 12 and 24 hours, the surface material was taken to determination of its GM-CSF levels in 22 patients and of IL-5 levels in 19 patients, by ELISA method.
Results: Reduction in GM-CSF expression on the experimental group at time 24 h (p< or = 0.05). The treated group presented significant GM-CSF expression between zero time and 12 h time (p= 0.013) showing the culture viability such as in the non-treated group. Tendency to decreasing IL-5 levels on the treated groups at 24 hours.
Conclusion: This study showed that mitomycin C was efficient in inhibiting GM-CSF synthesis with reduction of IL-5 secretion, but this fact needs complementary studies.
Figures
Similar articles
-
Effect of mitomycin C in eosinophilic nasal polyposis, in vivo: concentration of IL5 and GM-CSF, RT-PCR.Braz J Otorhinolaryngol. 2006 Jan-Feb;72(1):38-42. doi: 10.1016/s1808-8694(15)30032-x. Braz J Otorhinolaryngol. 2006. PMID: 16917551 Free PMC article.
-
Interleukin-3 interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps.Am J Otolaryngol. 1997 Jul-Aug;18(4):239-46. doi: 10.1016/s0196-0709(97)90003-x. Am J Otolaryngol. 1997. PMID: 9242874
-
[Expressions of immunoglobulin E, interleukin-5 and granulocyte-macrophage colony-stimulation factor in nasal polyps tissue].Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2004 May;18(5):276-8. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2004. PMID: 15311508 Chinese.
-
[Humoral regulation of eosinophilopoiesis by interleukin-3, granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin-5].Nihon Rinsho. 1993 Mar;51(3):565-70. Nihon Rinsho. 1993. PMID: 8492428 Review. Japanese.
-
[The assessment of Eo-CSF and cytokines as eosinopoietic factor].Nihon Rinsho. 1993 Mar;51(3):736-40. Nihon Rinsho. 1993. PMID: 8492450 Review. Japanese.
Cited by
-
The use of Mitomycin-C to reduce synechia in middle meatus in sinus surgery: preliminary results.Braz J Otorhinolaryngol. 2012 Oct;78(5):44-50. doi: 10.5935/1808-8694.20120007. Braz J Otorhinolaryngol. 2012. PMID: 23108819 Free PMC article.
-
Apoptosis in eosinophilic nasal polyps treated in vitro with mitomycin C.Braz J Otorhinolaryngol. 2012 Jun;78(3):32-7. doi: 10.1590/S1808-86942012000300007. Braz J Otorhinolaryngol. 2012. PMID: 22714844 Free PMC article.
-
Topical mitomycin C application post endoscopic removal of antrochoanal polyp.Laryngoscope Investig Otolaryngol. 2021 Jun 28;6(4):619-622. doi: 10.1002/lio2.598. eCollection 2021 Aug. Laryngoscope Investig Otolaryngol. 2021. PMID: 34401480 Free PMC article.
-
Therapeutic Strategies to Prevent the Recurrence of Nasal Polyps after Surgical Treatment: An Update and In Vitro Study on Growth Inhibition of Fibroblasts.J Clin Med. 2023 Apr 13;12(8):2841. doi: 10.3390/jcm12082841. J Clin Med. 2023. PMID: 37109177 Free PMC article. Review.
-
Azithromycin for the treatment of eosinophilic nasal polyposis: Clinical and histologic analysis.Allergy Rhinol (Providence). 2016 Jan;7(2):55-61. doi: 10.2500/ar.2016.7.0160. Epub 2016 Jul 26. Allergy Rhinol (Providence). 2016. PMID: 27465667 Free PMC article.
References
-
- Becker HMG, Guimarães RES, Nascimento E, Becker CG, Gonçalves DU, Crosara PFTB. Perfil das citocinas e tipificação de hla em pacientes com polipose nasossinusal eosinofílica tolerantes e intolerantes a aspirina. Rev Bras Oto. 2003;69(3):296–302.
-
- Voegels RL. Study of interleukins 1, 3, 4, 5 before and after surgery of patients with nasal polyposis. Otolaryngology Head And Neck Surgery. 2003;129(2):214.
-
- Mullol J, Xaubet A, Gaya A, Roca-Ferrer J, Lopez E, Fernandez JC, Fernandez MD, Picado C. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy. 1995;25(7):607–615. - PubMed
-
- Xaubet A, Mullol J, Lopez E, Roca-Ferrer J, Rozman M, Carrion T, Fabra JM, Picado C. Comparison of the role of nasal polyp and normal nasal mucosal epithelial cells on in vitro eosinophil survival. Mediation by GM-CSF and inhibition by dexamethasone. Clin Exp Allergy. 1994;24(4):307–317. - PubMed
-
- Jankowiski R. Eosinophils in the Pathophysiology of Nasal Polyposis. Acta Otolaryngol (Stockh) 1996;116:160–163. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources